Toho University Researchers Create Advanced Liver Cell Model

A research team from Toho University has made significant strides in drug metabolism research with the development of a new HepaRG cell line. Led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, along with Professor Yojiro Anzai and Lecturer Yohei Iizaka from the Faculty of Pharmaceutical Sciences, the team has engineered a human hepatocyte model that exhibits markedly enhanced activity of CYP2D6, a critical enzyme in drug metabolism.

This innovative model allows for a more relevant evaluation of drug-induced hepatotoxicity associated with CYP2D6, which is essential for improving drug safety assessments. The findings were published in the journal PLOS ONE on December 29, 2025, marking a notable advancement in the field of pharmacology.

Significance of the Research

The CYP2D6 enzyme plays a crucial role in the metabolism of approximately 25% of all medications on the market. Variations in CYP2D6 activity among individuals can lead to different drug responses, making it a focal point in personalized medicine. The new HepaRG cell line developed by the researchers provides a platform that closely mimics human liver function, enhancing the reliability of hepatotoxicity assessments.

Prior to this research, traditional models often failed to accurately represent human drug metabolism, which could lead to ineffective or harmful drug development. By overcoming these limitations, the new model is poised to contribute significantly to the understanding of drug interactions and liver toxicity.

Future Implications

The implications of this research extend beyond academic interest. Pharmaceutical companies can utilize this advanced model to conduct more precise evaluations of drug safety, potentially reducing the time and cost associated with bringing new drugs to market. The enhanced activity of CYP2D6 in the engineered cell line also opens avenues for studying the effects of genetic variations on drug metabolism, which is vital for developing tailored therapeutic strategies.

As the field of pharmacology continues to evolve, the work of the Toho University team highlights the importance of innovative research in addressing the complexities of drug interactions. Their contributions could play a pivotal role in improving patient outcomes and advancing the future of personalized medicine.